Cardiovascular disease is associated with extra-articular manifestations in patients with rheumatoid arthritis

Clinical Rheumatology

Volumn 28, Issue 7, 2009, Pages 767-775

  Ortega Hernandez, Oscar Danilo ^a   Pineda Tamayo, Ricardo ^b   Pardo, Aryce L ^c   Rojas Villarraga, Adriana ^a,b   Anaya, Juan Manuel ^a,b  

^a UNIVERSIDAD DEL ROSARIO   (Colombia)

^b Clinica Universitaria Bolivariana   (Colombia)

^c UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

Author keywords

Cardiovascular disease; Extra articular manifestations; HLA; Latin America; Rheumatoid arthritis; Smoking

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DISEASE MODIFYING ANTIRHEUMATIC DRUG; HLA ANTIGEN; RHEUMATOID FACTOR; STEROID; TUMOR NECROSIS FACTOR;

ADULT; AGE; ANEMIA; ANTIBODY TITER; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CLINICAL FEATURE; COLOMBIA; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; DNA POLYMORPHISM; EXTRA ARTICULAR RHEUMATOID ARTHRITIS; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENETIC RISK; GENETIC VARIABILITY; HUMAN; HYPERTENSION; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RHEUMATOID NODULE; SJOEGREN SYNDROME; THROMBOSIS;

ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; CARDIOVASCULAR DISEASES; COLOMBIA; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HISTOCOMPATIBILITY TESTING; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; INDIANS, SOUTH AMERICAN; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; RISK FACTORS; TIME FACTORS;

EID: 67349175002     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-009-1145-8     Document Type: Article

References (38)

1. Erhardt CC, Mumford PA, Venables PJ, Maini RN (1989) Factors predicting a poor life prognosis in rheumatoid arthritis: An eight year prospective study. Ann Rheum Dis 48:7-13
2. Aviña-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D (2008) Risk of cardiovascular mortality in patients with rheumatoid arthritis: A meta-analysis of observational studies. Arthritis Rheum 59:1690-1697
3. Ward MM (2008) Interpreting studies of cardiovascular mortality in rheumatoid arthritis: The importance of timing. Arthritis Rheum 59:1687-1689
4. Turesson C, O'Fallon WM, Crowson CS, Gabriel SE, Matteson EL (2003) Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis 62:722-727
5. Turesson C, McClelland RL, Christianson TJ, Matteson EL (2007) Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis. Ann Rheum Dis 66:70-75
6. Calgüneri M, Ureten K, Akif Oztürk M, Onat AM, Ertenli I, Kiraz S, Akdogan A (2006) Extra-articular manifestations of rheumatoid arthritis: Results of a university hospital of 526 patients in Turkey. Clin Exp Rheumatol 24:305-308
7. Nikolaisen C, Rekvig OP, Nossent HC (2005) Rheumatoid factor by laser nephelometry and Waaler-Rose assay: Prognostic value in patients with recent-onset rheumatoid arthritis. Scand J Rheumatol 34:269-276
8. Turesson C, Jacobsson L, Bergström U, Truedsson L, Sturfelt G (2000) Predictors of extra-articular manifestations in rheumatoid arthritis. Scand J Rheumatol 29:358-364
9. Bongartz T, Cantaert T, Atkins SR, Harle P, Myers JL, Turesson C, Ryu JH, Baeten D, Matteson EL (2007) Citrullination in extra-articular manifestations of rheumatoid arthritis. Rheumatology (Oxford) 46:70-75
10. Albano SA, Santana-Sahagun E, Weisman MH (2001) Cigarette smoking and rheumatoid arthritis. Semin Arthritis Rheum 31:146-159
11. Turesson C, O'Fallon WM, Crowson CS, Gabriel SE, Matteson EL (2002) Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. J Rheumatol 29:62-67
12. Turesson C, Eberhardt K, Jacobsson LT, Lindqvist E (2007) Incidence and predictors of severe extra-articular disease manifestations in an early rheumatoid arthritis inception cohort. Ann Rheum Dis 66:1543-1544
13. Liang KP, Liang KV, Matteson EL, McClelland RL, Christianson TJ, Turesson C (2006) Incidence of noncardiac vascular disease in rheumatoid arthritis and relationship to extraarticular disease manifestations. Arthritis Rheum 54:642-648
14. Turesson C, McClelland RL, Christianson TJ, Matteson EL (2007) Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis. Ann Rheum Dis 66:70-75
15. Libby P (2008) Role of inflammation in atherosclerosis associated with rheumatoid arthritis. Am J Med 121:S21-S23
16. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324
17. Gomez LM, Ruiz-Narvaez EA, Pineda-Tamayo R, Rojas-Villarraga A, Anaya JM (2007) TNF microsatellites polymorphism is associated with rheumatoid arthritis. Confirming evidence in north-western Colombians. Clin Exp Rheumatol 25:443-448
18. Anaya JM, Correa PA, Mantilla RD, Jimenez F, Kuffner T, McNicholl JM (2001) Rheumatoid arthritis in African Colombians from Quibdo. Semin Arthritis Rheum 31:191-198
19. Prevoo ML, van't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44-48
20. Patrick DL, Cheadle A, Thompson DC, Diehr P, Koepsell T, Kinne S (1994) The validity of self-reported smoking: A review and meta-analysis. Am J Public Health 84:1086-1093
21. Rojas-Villarraga A, Ortega-Hernandez OD, Gomez LF, Pardo AL, López-Guzmán S, Arango-Ferreira C et al (2008) Risk factors associated with different stages of atherosclerosis in colombian patients with rheumatoid arthritis. Semin Arhritis Rheum 38:71-82
22. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, endorsed by the British Diabetic Association (1998) Joint British recommendations on prevention of coronary heart disease in clinical practice. Heart 80:S1-S29
23. Correa PA, Tobón GJ, Citera G, Cadena J, Schneeberger E, Camargo JF et al (2004) Anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: Relation with clinical features, cytokines and HLA-DRB1. Biomedica 24:140-152
24. Hollingsworth PN, Dawkins RL, Peter JB (1996) Precise quantitation of antinuclear antibodies on HEp-2-cells without the need for serial dilution. Clin Diagn Lab Immunol 3:374-377
25. Correa PA, Gomez LM, Cadena J, Anaya JM (2005) Autoimmunity and tuberculosis. Opposite association with TNF polymorphism. J Rheumatol 32:219-224
26. Lee YH, Ji JD, Song GG (2007) Tumor necrosis factor-alpha promoter -308 A/G polymorphism and rheumatoid arthritis susceptibility: A metaanalysis. J Rheumatol 34:43-49
27. Anaya JM, Correa PA, Mantilla RD, Arcos-Burgos M (2002) Rheumatoid arthritis association in Colombian population is restricted to HLA-DRB1*04 QRRAA alleles. Genes Immun 3:56-58
28. Gregersen PK, Silver J, Winchester RJ (1989) The shared epitope hypothesis: An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 30:1205-1213
29. Tezenas du Montcel S, Michou L, Petit-Teixeira E, Osorio J, Lemaire I, Lasbleiz S et al (2005) New Classification of HLA-DRB1 Alleles supports the shared epitope hypothesis of rheumatoid arthritis susceptibility. Arthritis Rheum 52:1063-1068
30. Anaya JM (2006) Severe rheumatoid valvular heart disease. Clin Rheumatol 25:743-745
31. Kim SK, Park SH, Shin IH, Choe JY (2008) Anti-cyclic citrullinated peptide antibody, smoking, alcohol consumption, and disease duration as risk factors for extraarticular manifestations in Korean patients with rheumatoid arthritis. J Rheumatol 35:995-1001
32. Turesson C, Jacobsson L, Bergström U (1999) Extra-articular rheumatoid arthritis: Prevalence and mortality. Rheumatology (Oxford) 38:668-674
33. Saag KG, Cerhan JR, Kolluri S, Ohashi K, Hunninghake GW, Schwartz DA (1997) Cigarette smoking and rheumatoid arthritis severity. Ann Rheum Dis 56:463-469
34. Zonana-Nacach A, Santana-Sahagún E, Jiménez-Balderas FJ, Camargo-Coronel A (2008) Prevalence and factors associated with metabolic syndrome in patients with rheumatoid arthritis and systemic lupus erythematosus. J Clin Rheumatol 14:74-77
35. Libby P (2008) Role of inflammation in atherosclerosis associated with rheumatoid arthritis. Am J Med 121:S21-S31
36. Dessein PH, Joffe BI, Singh S (2005) Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis. Arthritis Res Ther 7:R634-R643
37. Korkmaz C, Us T, Kaşifoǧlu T, Akgün Y (2006) Anti-cyclic citrullinated peptide (CCP) antibodies in patients with long-standing rheumatoid arthritis and their relationship with extra-articular manifestations. Clin Biochem 39:961-965
38. Turesson C, Jacobsson LT, Sturfelt G, Matteson EL, Mathsson L, Rönnelid J (2007) Rheumatoid factor and antibodies to cyclic citrullinated peptides are associated with severe extra-articular manifestations in rheumatoid arthritis. Ann Rheum Dis 66:59-64